ArticleDiabetology & metabolic syndrome2023

A novel inflammatory biomarker, high-sensitivity C-reactive protein-to-albumin ratio, is associated with 5-year outcomes in patients with type 2 diabetes who undergo percutaneous coronary intervention.

Jiawen Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.